Modulation of intestinal P-glycoprotein function by cremophor EL and other surfactants by an in vitro diffusion chamber method using the isolated rat intestinal membranes.
暂无分享,去创建一个
Akira Yamamoto | T. Fujita | A. Yamamoto | Yasushi Shono | Yasushi Shono | Takuya Fujita | Hisayo Nishihara | Yasuyuki Matsuda | Shiori Furukawa | Naoki Okada | N. Okada | Y. Matsuda | S. Furukawa | Hisayo Nishihara | Yasuyuki Matsuda | Shiori Furukawa
[1] K. Audus,et al. Effects of poly(ethylene glycol) on efflux transporter activity in Caco-2 cell monolayers. , 2002, Journal of pharmaceutical sciences.
[2] P Langguth,et al. Intestinal drug efflux: formulation and food effects. , 2001, Advanced drug delivery reviews.
[3] A. F. Castro,et al. Mechanism of inhibition of P-glycoprotein-mediated drug transport by protein kinase C blockers. , 1999, Biochemical pharmacology.
[4] P Langguth,et al. P-Glycoprotein (P-gp) mediated efflux in Caco-2 cell monolayers: the influence of culturing conditions and drug exposure on P-gp expression levels. , 1998, Journal of pharmaceutical sciences.
[5] Muranishi Shozo,et al. Assessment of enhancing ability of medium-chain alkyl saccharides as new absorption enhancers in rat rectum , 1992 .
[6] Y. Sai,et al. Active Secretion of Drugs from the Small Intestinal Epithelium in Rats by P‐Glycoprotein Functioning as an Absorption Barrier , 1996, The Journal of pharmacy and pharmacology.
[7] G. Grass,et al. In Vitro Measurement of Gastrointestinal Tissue Permeability Using a New Diffusion Cell , 1988, Pharmaceutical Research.
[8] James E Polli,et al. Effects of nonionic surfactants on membrane transporters in Caco-2 cell monolayers. , 2002, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences.
[9] K. Higaki,et al. Role of P-glycoprotein as a secretory mechanism in quinidine absorption from rat small intestine. , 1998, Journal of pharmaceutical sciences.
[10] Ronald T Borchardt,et al. A comparison of commonly used polyethoxylated pharmaceutical excipients on their ability to inhibit P-glycoprotein activity in vitro. , 2002, Journal of pharmaceutical sciences.
[11] V. H. Lee,et al. Age-dependent Expression of P-Glycoprotein gp17O in Caco-2 Cell Monolayers , 1996, Pharmaceutical Research.
[12] T. Fujita,et al. Enhanced Permeability of Insulin across the Rat Intestinal Membrane by Various Absorption Enhancers: Their Intestinal Mucosal Toxicity and Absorption‐enhancing Mechanism of n‐Lauryl‐β‐D‐maltopyranoside , 1999, The Journal of pharmacy and pharmacology.
[13] R. Borchardt,et al. The Use of Surfactants to Enhance the Permeability of Peptides Through Caco-2 Cells by Inhibition of an Apically Polarized Efflux System , 1996, Pharmaceutical Research.
[14] R. Borchardt,et al. Mechanistic roles of neutral surfactants on concurrent polarized and passive membrane transport of a model peptide in Caco-2 cells. , 1997, Journal of pharmaceutical sciences.
[15] B. Hirst,et al. Intestinal secretion of drugs. The role of P-glycoprotein and related drug efflux systems in limiting oral drug absorption , 1997 .
[16] T. Murakami,et al. Transport of rhodamine 123, a P-glycoprotein substrate, across rat intestine and Caco-2 cell monolayers in the presence of cytochrome P-450 3A-related compounds. , 1999, The Journal of pharmacology and experimental therapeutics.
[17] V. Ling,et al. Effects of nonionic detergents on P-glycoprotein drug binding and reversal of multidrug resistance. , 1993, Cancer research.
[18] K. Anderson,et al. Reversal of multidrug resistance phenotype by surfactants: relationship to membrane lipid fluidity. , 1995, Archives of biochemistry and biophysics.
[19] D. Miller,et al. Use of rhodamine 123 to examine the functional activity of P-glycoprotein in primary cultured brain microvessel endothelial cell monolayers. , 1996, Life sciences.
[20] B. Williams,et al. Reversal of the multidrug resistance phenotype with cremophor EL, a common vehicle for water-insoluble vitamins and drugs. , 1990, Cancer research.